Wtap-mediated m6a modification modulates bone marrow mesenchymal stem cells differentiation potential and osteoporosis

HIGHLIGHTS

• who: Yunhao You from the Human specimens The specimens were obtained from female patients and control subjects without osteoporosis or other bone-related anomaliesAll subjects with other diseases and smoking or drinking histories were excluded. All participants signed written informed consent. Specimen collection was conducted by the Department of Orthopedics, Qilu Hospital of Shandong University. This study was approved by the Medical Ethics Committee of the Qilu Hospital of Shandong University. have published the article: WTAP-mediated m6A modification modulates bone marrow mesenchymal stem cells differentiation potential and osteoporosis, in the Journal: (JOURNAL) of 22/Oct/2022 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.